|
On April 29, 2024, Accord BioPharma, Inc. announced that the U.S. Food and Drug Administration (FDA) approved HERCESSI (trastuzumab-strf).
Category:
News and Media
New License Exception MED under the Export Administration Regulations ("EAR") authorizes the export, reexport, and/or transfer of EAR99 "medical devices,"...
Category:
News and Media
New License Exception MED under the Export Administration Regulations ("EAR") authorizes the export, reexport, and/or transfer of EAR99 "medical devices,"...
Category:
News and Media
All news |
||||||||||||||||||
|